Season 5 - Slowdown 1: Q & A

The public's perception of drugs and drug use is changing. And with it, the decrim movement is in full swing. Soon the FDA is expected to approve psychedelic-assisted therapy. But are these steps enough for Black people in America? Enough to keep us safe in a world of racial ... Show More

We’ve explored the psychedelic renaissance with Black scientists, therapists and everyday people in search of healing. In this season closer, host Tonya Mosley finds her own path towards healing. Also, some parting words from our Wise Ones: Ernestine Mosley, Dr. Monnica Williams, ... Show More

Happy Summer! We're stepping into your feed to share a conversation Tonya recently had with singer, songwriter, and producer Madison McFerrin. Madison has been on her own liberation journey the last few years, and it’s evident with her new album “I Hope You Can Forgive Me." T ... Show More

It's time to make psychiatry more psychedelic, says psychiatrist Benjamin Lewis. Sharing results from his clinical trial on psychedelic-assisted therapy, he highlights how group therapy paired with the safe use of psilocybin, a compound found in magic mushrooms, has the potential ... Show More

Could psychedelics help us heal from trauma and mental illnesses? Researcher Rick Doblin has spent the past three decades investigating this question, and the results are promising. In this fascinating dive into the science of psychedelics, he explains how drugs like LSD, psilocy ... Show More

Hallucinogenic drugs are currently illegal, but they were once commonly used in psychological treatment. In this episode, Josh and Chuck discuss the rise and fall of psychedelics in treating mood disorders -- and why they're starting to gain favor again. Learn more about your ad- ... Show More

In just a few years, psychedelics have gone from being a symbol of the 1960s counterculture to being touted as highly promising mental health treatments. Dr. Albert Garcia-Romeu, PhD, of Johns Hopkins University, talks about whether the research backs up the hype; the state of ps ... Show More

Three leading researchers from the Mount Sinai Health System discuss how ketamine, cannabis, and ecstasy are being used (or studied) to treat everything from severe depression to addiction to PTSD. We discuss the upsides, downsides, and regulatory puzzles. 

Bad trips, anti-drug PSAs, and the crackdown under the Controlled Substances Act of 1970 helped stigmatize psychedelics in the U.S. But now, there’s renewed clinical inquiry into whether these drugs can ease emotional trauma. To understand the future of psychedelics, Audie calls ... Show More

[video available on spotify] i've dabbled in the world of psychedelics a little bit. i've taken mushrooms a few times, but i really don't know a lot about psychedelics. however, it's becoming an increasingly more relevant topic as it's been revealed that they can help with mental ... Show More